Maravai LifeSciences (MRVI) stock was downgraded by Baird based on the company's decision to delay its quarterly earnings report and 10-K. Read more here.
Baird downgraded Maravai Lifesciences (MRVI) to Neutral from Outperform with a price target of $3, down from $9, after the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results